Dr. Xiuning Le from MD Anderson Cancer Center provides answers to 9 questions focusing on METex14 in advanced NSCLC. View it now at

View the Expert Interview on Specialist Insights in Urothelial Cancer which features specific expert insights on the topics related to the faculty presentations and the key questions discussed during the preceptorship.

View featured discussions of our webinar focusing on how to use new targeted treatment options to optimize care of patients in advanced NSCLC with METex14 skipping mutations.

On September 3, 2024 is our MET@Learning APAC Live Webinar: Focus on METex14 in Advanced NSCLC. Visit our company website to learn more and register!

Listen to the experts' panel discussion and Dr. Bamias' summary of the topic 'Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer'

Listen to clinical cases `Second-line and salvage treatment options after maintenance immunotherapy´ & ´Second-line and salvage treatment options after platinum-based chemotherapy´ in Podcast.

Listen to Dr. Philippe Barthélémy`s Second-line and salvage treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC) in Podcast.

Listen to the experts' panel discussion and Dr. Maluf's summary of the topic 'Reconsidering the optimization of first-line treatment strategies in locally advanced or metastatic urothelial cancer'

Listen to Clinical Cases `First-line treatment with maintenance immunotherapy for a platinum-eligible patient´ & ´First-line treatment with mono-immunotherapy for a cisplatin-ineligible patient´ at:

Dr. Enrique Grande's First-line treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC) is now also available as podcast. Listen to it at

View new session of the ‘Best Practice Exchange in Clinical Case Scenarios’ to listen to experts in UC discussing the latest evidence supporting the optimal utilization of sequential treatments.

View the ‘Best Practice Exchange in Clinical Case Scenarios’ program to listen to experts in the field discussing the latest evidence supporting the use of new therapies in clinical practice.

View the program and get CME credits! Listen to experts in the field discussing the latest evidence supporting the use of the therapies in clinical practice of advanced urothelial cancer! View now

Gain practical advice on how to utilize advanced molecular testing strategies to not miss rare actionable biomarkers, and how to use new targeted treatment options to optimize care of NSCLC patients with specific molecular alterations.

Watch the expert interview on 'FAQs for Second-Line (2L) and Salvage Treatments in Urothelial Cancer' to gain comprehensive insights from leading experts.

Watch the expert interview on 'FAQs for Muscle-Invasive Bladder Cancer (MIBC)' to gain comprehensive insights from leading experts.  

Watch the expert interview on 'FAQs for Non-Muscle-Invasive Bladder Cancer (NMIBC)' to gain comprehensive insights from leading experts.

The 2023 World Conference on Lung Cancer (WCLC 2023) held in September covered some exciting developments in the field of lung cancer, with a focus on multidisciplinary approaches in diagnosis, treatment, research, and care. View the highlights at

Watch the expert interview on 'Frequently Asked Questions (FAQs) for 1L Treatment Decision-making' to gain comprehensive insights from leading expert – Dr. Enrique Grande from MD Anderson Cancer Center Madrid.

The US FDA approved six new indications for cancer management in August 2023. Of these approvals, two were for multiple myeloma. The remainder were for solid tumors of the lung, prostate, and colon. Learn more at